Abstract:Background: Various factors influence treatment and outcomes in tibial plateau fractures. Bone defects are among them. Many materials have been proposed to address this problem: allograft, bone-cements and various bone substitutes (BSM). Cal-Cemex (β-tricalciophosphate and polymethylmethacrylate) is a new hybrid bi-component BSM. A retrospective multicenter study was conducted based on the clinical experience of three European Hospitals, to demonstrate its clinical effectiveness, versatility and safety. Materials and methods: From December 2016 to March 2022, 45 displaced tibial plateau fractures were treated with internal fixation and augmentation using Cal-Cemex. The average age was 55.9 years. According to Schatzker classification, we included 13 type II, 24 type III, 3 type V and 4 type VI fractures. The postoperative follow-up (FU) consisted of clinical and radiological examinations at 6 and 12 weeks and 1 year after surgery. A CT scan was performed preoperatively and 1 year after surgery. Full weight bearing was permitted after less than 6 weeks. Clinical data were collected from patient charts, while functional data were evaluated using the Rasmussen knee function score, the KOOS score and the Hospital for Special Surgery knee rating score (HSS), to evaluate the range of motion, axis and functionality of the knee. Results: The average FU was 42.8 months. CT scans taken at 1 year demonstrated a good surface osteointegration without radiolucent lines or osteolysis with good evidence of interdigitation and even bone ingrowth. At 1-year FU, the mean Rasmussen score was 24.7, the mean KOOS score was 90.7 and the mean HSS was 89.9 and the average full weight-bearing period 34.9. No patients had hardware failure or fracture secondary displacement. Discussion: Cal-Cemex combines biological features and good mechanical performances. It guarantees biocompatibility and osteoconductivity, although it is not fully reabsorbable; β-tricalciophosphate component gives macro- and microporosity that allow fluids to penetrate inside the material, to stimulate bone ingrowth. Conclusions: The study suggests that Cal-Cemex is an option for tibial plateau fractures, where augmentation and support are necessary for early full weight bearing. The absence of major complications, ease of application, the possibility to cut and perforate this material support its extensive use in bone augmentation for trauma cases.

Time to full weight-bearing with the use of a calcium sulfate-calcium phosphate bone substitute as a bone void filler following extended curettage in the treatment of primary benign bone tumours

Complete twelve month bone remodeling with a bi-phasic injectable bone substitute in benign bone tumors: a prospective pilot study

Curettage of benign bone tumors and tumor like lesions: A retrospective analysis

Xenograft and calcium sulphate in treating benign bone tumor

The Use of Calcium Sulfate in the Treatment of Bone Neoplasnis

Preliminary results of Highly Injectable Bi-Phasic Bone Substitute (CERAMENT) in the treatment of benign bone tumors and tumor-like lesions

Extended curettage for tumour-induced osteomalacia in the bone

Use of bone graft substitutes in the management of tibial plateau fractures

[Physicochemical and Sustained Drug Release Properties of Calcium Phosphate Cement/amifostine/cisplatin Complex and Its Effect in Repairing Bone Defect Due to Tumor Resection in Rabbits].

Efficacy of Cal-Cemex as bone substitute for tibial plateau fractures

Traumatic Fracture Treatment: Calcium Phosphate Bone Substitute Case–Control Study in Humerus, Radius, Tibia Fractures—Assessing Efficacy and Recovery Outcomes

How to Fill the Cavity after Curettage of Giant Cell Tumors Around the Knee? A Multicenter Analysis

Preclinical safety and efficacy evaluation of 'BioCaS' bioactive calcium sulfate bone cement

Outcomes after extensive manual curettage and limited burring for atypical cartilaginous tumour of long bone

Novel fully interconnected porous hydroxyapatite ceramic in surgical treatment of benign bone tumor

Clinical observation of mineralized collagen bone grafting after curettage of benign bone tumors

[Repair of Bone Defect Due to Tumor Resection with Self-Setting CPC in Children].

Safety, osseointegration, and bone ingrowth analysis of PMMA-based porous cement on animal metaphyseal bone defect model

Dual-functional porous and cisplatin-loaded polymethylmethacrylate cement for reconstruction of load-bearing bone defect kills bone tumor cells

Clinical Application of a New Mixture of Calcium Sulfate and Demineralized Bone Matrix

Treatment of Aneurysmal Bone Cysts by Minimally Invasive Curettage and Allogenic Bone Impaction Grafting: Mid-to Long-term Results